These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 6751521

  • 1. Apparent lack of immunogenicity of estrogen-induced testicular Leydig cell tumors in BALB/c mice.
    Huseby RA, Page RH.
    Cancer Res; 1982 Nov; 42(11):4332-8. PubMed ID: 6751521
    [Abstract] [Full Text] [Related]

  • 2. Dormancy versus extinction of mouse Leydig cell tumors following endocrine-induced regression.
    Huseby RA.
    Cancer Res; 1983 Nov; 43(11):5365-78. PubMed ID: 6616470
    [Abstract] [Full Text] [Related]

  • 3. Effects of tamoxifen on estrogen-induced enhancement or inhibition of tumor growth in mouse Leydig cell tumor lines.
    Sato B, Maeda Y, Nishizawa Y, Noma K, Kishimoto S, Matsumoto K.
    Cancer Res; 1984 Oct; 44(10):4386-91. PubMed ID: 6467199
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Changes in fine structure accompanying estrogen-induced tumorigenesis of Leydig cells in the mouse testis.
    Kurland G, Christensen AK, Huseby RA.
    Cancer Res; 1975 Jul; 35(7):1671-86. PubMed ID: 236824
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Estrogen-induced Leydig cell tumor in the mouse: a model system for the study of carcinogenesis and hormone dependency.
    Huseby RA.
    J Toxicol Environ Health Suppl; 1976 Jul; 1():177-92. PubMed ID: 11351
    [Abstract] [Full Text] [Related]

  • 10. [Immunological studies on mouse testicular tumor. Humoral antibody response against testicular interstitial cell tumor in tumor-bearing mice (author's transl)].
    Osato K, Ikoma F.
    Nihon Hinyokika Gakkai Zasshi; 1975 Oct; 66(10):683-8. PubMed ID: 1240545
    [No Abstract] [Full Text] [Related]

  • 11. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors.
    Korbelik M, Dougherty GJ.
    Cancer Res; 1999 Apr 15; 59(8):1941-6. PubMed ID: 10213504
    [Abstract] [Full Text] [Related]

  • 12. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
    Morecki S, Yacovlev E, Gelfand Y, Uzi I, Slavin S.
    J Immunother; 2001 Apr 15; 24(2):114-21. PubMed ID: 11265768
    [Abstract] [Full Text] [Related]

  • 13. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
    Maeda Y, Sato B, Noma K, Kishimoto S, Koizumi K, Aono T, Matsumoto K.
    Cancer Res; 1983 Sep 15; 43(9):4091-7. PubMed ID: 6871850
    [Abstract] [Full Text] [Related]

  • 14. Demonstration of a direct carcinogenic effect of estradiol on Leydig cells of the mouse.
    Huseby RA.
    Cancer Res; 1980 Apr 15; 40(4):1006-13. PubMed ID: 7357531
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep 15; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.